HomeAI · summaries
Storia in 2 fonti
Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s asset
The decision comes after tominersen did no better than placebo in a Phase 2 trial with patients in the earliest stages of the disease.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Roche scraps two Ionis-partnered Huntington’s drugs
The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal…
- ·
endpoints.news
Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s asset
The decision comes after tominersen did no better than placebo in a Phase 2 trial with patients in the earliest stages of the disease.